Inventor · disambiguated record
Vsevolod Ivanovich Kiselev
Also filed as: KISELEV VSEVOLOD IVANOVICH
4 granted patents·3 pending applications·14 citations·filing 2004–2016
68Inventor score
Files withKISELEV VSEVOLOD IVANOVICH3NORDIC LABS LTD2AKTSIONERNOE OBSCHESTVO VELES FARMA1ZAKRYTOE AKTSIONERNOE OBSCHESTVO VELES FARMA1
Top patents by PatentIndex Score
7 records- 0177US8697123B2Medication on the basis of 3,3′-diindolylmethane (DIM) with high-bioavailability and its use in treatment of human hyperplastic and inflammatory diseasesKISELEV VSEVOLOD IVANOVICH·Filed 2011·Granted Apr 15, 2014·8 cites·6 claims
- 0269US8791150B2Pharmaceutical composition for peroral administration of diindolylmethaneKISELEV VSEVOLOD IVANOVICH·Filed 2010·Granted Jul 29, 2014·5 cites·3 claims
- 0361US9308270B2Pharmaceutical composition on the basis of nanomicelles containing epigallocatechin gallate and a method of administration thereof to treat atopic dermatitis, Crohn's disease, adenomyosis, and hyperplastic diseases of the prostate glandNORDIC LABS LTD·Filed 2014·Granted Apr 12, 2016·1 cites·6 claims
- 0442US9393230B2Pharmaceutical composition on the basis of phyto-nutrients with increased bioavailability, having anti-tumor activity, and method for producing said composition (alternatives)NORDIC LABS LTD·Filed 2013·Granted Jul 19, 2016·0 cites·3 claims
- 0539US2014303225A1Pharmaceutical composition for peroral administration of 3,3'-diindolylmethaneZAKRYTOE AKTSIONERNOE OBSCHESTVO VELES FARMA·Filed 2014·Application pending·0 cites
- 0639US2008267982A1Methods Kits and Compositions for the Developement and Use of Monoclonal Antibodies Specific to Anbtigens of Low ImmunogenicityKISELEV VSEVOLOD IVANOVICH·Filed 2004·Application pending·0 cites
- 0735US2020179337A1Means for treating sexually transmitted infectionsAKTSIONERNOE OBSCHESTVO VELES FARMA·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Vsevolod Ivanovich Kiselev files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →